Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
| Brand name | CLOMIPRAMINE HYDROCHLORIDE |
| Generic name | CLOMIPRAMINE HYDROCHLORIDE CAPSULES |
| Active ingredient(s) | CLOMIPRAMINE HYDROCHLORIDE |
| Distributed by / for | Lupin Pharmaceuticals Inc. |
| NDC | 68180-492-01 |
| Full product label | clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide. |
| Quantity | 2,724 bottles |
| Recall initiated | 2025-06-27 |
| Report date | 2025-07-30 |
| Recall completed | 2026-01-05 |
| Recall number | D-0537-2025 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Naples FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗